A detailed history of National Bank Of Canada transactions in Uni Qure N.V. stock. As of the latest transaction made, National Bank Of Canada holds 1,205 shares of QURE stock, worth $6,868. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,205
Previous 1,205 -0.0%
Holding current value
$6,868
Previous $5,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$3.78 - $10.12 $1,285 - $3,440
-340 Reduced 22.01%
1,205 $5,000
Q1 2024

May 13, 2024

BUY
$4.82 - $6.93 $4,154 - $5,973
862 Added 126.21%
1,545 $8,000
Q4 2023

Feb 06, 2024

BUY
$5.63 - $8.27 $591 - $868
105 Added 18.17%
683 $4,000
Q3 2023

Oct 10, 2023

BUY
$6.71 - $11.83 $845 - $1,490
126 Added 27.88%
578 $3,000
Q2 2023

Jul 26, 2023

BUY
$11.12 - $22.2 $4,170 - $8,325
375 Added 487.01%
452 $5,000
Q4 2022

Jan 24, 2023

BUY
$18.12 - $27.32 $1,395 - $2,103
77 New
77 $0

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $266M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.